Actions of GLP-1 in target tissues
Your prescriber uses the OSA pathway, not the Bridge
Renal function decline, particularly in dehydrated patients with pre-existing kidney disease, requires baseline and periodic monitoring
In addition, a meta-analysis of 1193 patients with baseline SGLT2i use in AMPLITUDE-O and Harmony Outcomes revealed an HR for MACE of 0.78 (95% CI 0.491.24) with SGLT2is and 0.77 (95% CI 0.680.87) without SGLT2is ( P -value for interaction 0.95), and an HR for HHF of 0.34 (95% CI 0.120.96) with SGLT2is and 0.72 (95% CI 0.550.92) without SGLT2is ( P -value for interaction 0.18) [48]
Injection site reactions follow a predictable pattern that can be managed through rotation
6 Day St S, Lidcombe NSW 2141(No.A93-95) 002+61+488663616 / / / AU$0.00 0 + 0 . AU$20.00 TWD: NT$420 2027/03 0.1 : Eaoron Eaoron -V AU$12.00 TWD: NT$252 Eaoron 120ml AU$10.00 TWD: NT$210 EZZ25g*7 ( AU$14.00 TWD: NT$294 Eaoron 120ml AU$11.00 TWD: NT$231 Eaoron 50ml AU$15.00 TWD: NT$315 Eaoron AU$8.00 AU$18.00 TWD : NT$168 - NT$378 Eaoron 15g AU$17.00 TWD: NT$357 Eaoron 5g*28 Bags () AU$18.00 TWD: NT$378